DSP-1053

· Sumitomo Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DSP-1053, covering 2014-06-18 to 2014-06-18. Get the full timeline:

Most recent: Clinical Trial Update: A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive Disorder [Phase 1]

See pricing